Federated Hermes, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,694,060 shares of ARCT stock, worth $103 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,694,060

Previous 4,694,060 -0.0%

Holding current value

$103 Million

Previous $49.7 Million 22.85%

% of portfolio

0.12%

Previous 0.11%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$24.35 - $44.39 $31,947 - $58,239	-1,312 Reduced 0.03%	4,694,060 $114 Million
Q1 2024 May 14, 2024	SELL	$31.23 - $42.99 $504,052 - $693,858	-16,140 Reduced 0.34%	4,695,372 $159 Million
Q3 2023 Nov 13, 2023	SELL	$25.44 - $37.35 $1.7 Million - $2.5 Million	-66,988 Reduced 1.4%	4,711,512 $120 Million
Q1 2023 May 08, 2023	BUY	$14.72 - $23.97 $7.93 Million - $12.9 Million	538,946 Added 12.71%	4,778,500 $115 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $9.5 Million - $15.5 Million	672,057 Added 18.84%	4,239,554 $71.9 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $83,520 - $141,632	6,400 Added 0.18%	3,567,497 $52.9 Million
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $2.46 Million - $6.26 Million	-200,803 Reduced 5.34%	3,561,097 $56.1 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $1.18 Million - $2.65 Million	66,971 Added 1.81%	3,761,900 $101 Million
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $22.2 Million - $30.9 Million	649,641 Added 21.33%	3,694,929 $137 Million
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $481,989 - $1.01 Million	17,288 Added 0.57%	3,045,288 $146 Million
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $4.51 Million - $7.37 Million	-175,000 Reduced 5.46%	3,028,000 $102 Million
Q1 2021 May 13, 2021	SELL	$38.75 - $86.92 $9.68 Million - $21.7 Million	-249,810 Reduced 7.23%	3,203,000 $132 Million
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $71.9 Million - $257 Million	2,076,135 Added 150.81%	3,452,810 $150 Million
Q3 2020 Nov 12, 2020	BUY	$37.49 - $63.19 $28.6 Million - $48.1 Million	761,631 Added 123.83%	1,376,675 $59.1 Million
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $7.79 Million - $35.8 Million	615,044 New	615,044 $28.7 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Arcturus Therapeutics Holdings Inc. Transaction History